Longitudinal monitoring of Type 1 Diabetes progression to disease onset
RNA-seq (gene expression) · mouse · 120 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 120 samples: 120 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Longitudinal monitoring of type 1 diabetes progression to disease onsetScience advances · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299709_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1276107 and SRA study SRP591713. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 120 sample titles: 120 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9044536 NOD mouse, progressor to hyperglycemia, 6 weeks of age, mouse 1 (biol rep 1)
- GSM9044537 NOD mouse, progressor to hyperglycemia, 6 weeks of age, mouse 2 (biol rep 2)
- GSM9044538 NOD mouse, progressor to hyperglycemia, 6 weeks of age, mouse 3 (biol rep 3)
- GSM9044539 NOD mouse, progressor to hyperglycemia, 6 weeks of age, mouse 4 (biol rep 4)
- GSM9044540 NOD mouse, progressor to hyperglycemia, 5 weeks before onset, mouse 1 (biol rep 1)
- GSM9044541 NOD mouse, progressor to hyperglycemia, 5 weeks before onset, mouse 2 (biol rep 2)
- GSM9044542 NOD mouse, progressor to hyperglycemia, 5 weeks before onset, mouse 3 (biol rep 3)
- GSM9044543 NOD mouse, progressor to hyperglycemia, 5 weeks before onset, mouse 4 (biol rep 4)
- GSM9044544 NOD mouse, progressor to hyperglycemia, 5 weeks before onset, mouse 5 (biol rep 5)
- GSM9044545 NOD mouse, progressor to hyperglycemia, 3 weeks before onset, mouse 1 (biol rep 1)
- GSM9044546 NOD mouse, progressor to hyperglycemia, 3 weeks before onset, mouse 2 (biol rep 2)
- GSM9044547 NOD mouse, progressor to hyperglycemia, 3 weeks before onset, mouse 3 (biol rep 3)
- GSM9044548 NOD mouse, progressor to hyperglycemia, 3 weeks before onset, mouse 4 (biol rep 4)
- GSM9044549 NOD mouse, progressor to hyperglycemia, 3 weeks before onset, mouse 5 (biol rep 5)
- GSM9044550 NOD mouse, progressor to hyperglycemia, 1 week before onset, mouse 1 (biol rep 1)
- GSM9044551 NOD mouse, progressor to hyperglycemia, 1 week before onset, mouse 2 (biol rep 2)
- GSM9044552 NOD mouse, progressor to hyperglycemia, 1 week before onset, mouse 3 (biol rep 3)
- GSM9044553 NOD mouse, progressor to hyperglycemia, 1 week before onset, mouse 4 (biol rep 4)
- GSM9044554 NOD mouse, progressor to hyperglycemia, 1 week before onset, mouse 5 (biol rep 5)
- GSM9044555 NOD mouse, progressor to hyperglycemia, onset, mouse 1 (biol rep 1)
- GSM9044556 NOD mouse, progressor to hyperglycemia, onset, mouse 2 (biol rep 2)
- GSM9044557 NOD mouse, progressor to hyperglycemia, onset, mouse 3 (biol rep 3)
- GSM9044558 NOD mouse, progressor to hyperglycemia, onset, mouse 4 (biol rep 4)
- GSM9044559 NOD mouse, progressor to hyperglycemia, onset, mouse 5 (biol rep 5)
- GSM9044560 NOR mouse, 6 weeks of age, mouse 1 (biol rep 1)
- GSM9044561 NOR mouse, 6 weeks of age, mouse 2 (biol rep 2)
- GSM9044562 NOR mouse, 6 weeks of age, mouse 4 (biol rep 3)
- GSM9044563 NOR mouse, 6 weeks of age, mouse 5 (biol rep 4)
- GSM9044564 NOR mouse, 10 weeks of age, mouse 1 (biol rep 1)
- GSM9044565 NOR mouse, 10 weeks of age, mouse 2 (biol rep 2)
- GSM9044566 NOR mouse, 10 weeks of age, mouse 3 (biol rep 3)
- GSM9044567 NOR mouse, 10 weeks of age, mouse 4 (biol rep 4)
- GSM9044568 NOR mouse, 10 weeks of age, mouse 5 (biol rep 5)
- GSM9044569 NOR mouse, 14 weeks of age, mouse 1 (biol rep 1)
- GSM9044570 NOR mouse, 14 weeks of age, mouse 2 (biol rep 2)
- GSM9044571 NOR mouse, 14 weeks of age, mouse 3 (biol rep 3)
- GSM9044572 NOR mouse, 14 weeks of age, mouse 4 (biol rep 4)
- GSM9044573 NOR mouse, 14 weeks of age, mouse 5 (biol rep 5)
- GSM9044574 NOR mouse, 18 weeks of age, mouse 1 (biol rep 1)
- GSM9044575 NOR mouse, 18 weeks of age, mouse 3 (biol rep 2)
+ 80 more — browse all 120 samples with per-sample file links →
- GSE241770 ACSS2 mediates an epigenetic pathway to regulate maternal Beta-cell adaptation and progression of gestational diabetes (scRNA-Seq) 7899 samples shares progression, diabetes
- GSE306097 Distinct immunometabolic signatures of type 1 versus type 2 diabetes in a murine model of myocardial infarction 55 samples shares diabetes, type
- GSE325466 Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism response to type 1 diabetes, SGLT1/2 inhibition or GLP1 receptor agonism 54 samples shares diabetes, type
- GSE225224 Transcriptomic analysis of peripheral neuropathy in a high-fat diet-induced mouse model of type 2 diabetes 46 samples shares diabetes, type
- GSE310456 Adipose tissue-derived microRNAs as epigenetic modulators of type 2 diabetes [DPDR_RNASEQ] 30 samples shares diabetes, type
- GSE241180 Fibroblast-specific TGF-b signaling mediates dysfunction, fibrosis and hypertrophy in a mouse model of obesity-associated type 2 diabetes 27 samples shares diabetes, type
- GSE288503 Secreted chemokines and transcriptomic analyses reveal diverse inflammatory and degenerative processes in the intervertebral disc of the STZ-HFD mouse model of Type 2 diabetes 14 samples shares diabetes, type
- GSE241176 Fibroblast-specific TGF-b signaling mediates dysfunction, fibrosis and hypertrophy in a mouse model of obesity-associated type 2 diabetes [RNA-seq: Smad3 in dbdb] 12 samples shares diabetes, type
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.